In agreement with our study, Sockolosky et al. [30] examined the effects of CD47 blockade in B16 mouse melanoma and demonstrated no increase in phagocytosis and no inhibition of tumour growth following treatment with a CD47 nanobody. The gene discussed is CD47; the disease is melanoma.